Becker's Oncology

A cancer mapping technology developed by researchers at Baltimore-based Johns Hopkins Medicine has been chosen to participate in Anthropic’s AI for Science program.  The research project, called AstroPath, is led by Johns Hopkins astrophysicist Alexander Szalay, PhD, and Johns Hopkins’…

Charlottesville, Va.-based UVA Health will launch the Suri Center for Gene Therapy at the University of Virginia’s Paul and Diane Manning Institute of Biotechnology. The center is funded by a gift from Vishal and Anubha Suri, according to an Oct.…

Pairing KRAS-targeted drugs with medicines that stop cancer cells from dividing may keep those therapies working longer in pancreatic and lung cancers, according to a preclinical study published Oct. 28 in Cancer Research. Researchers from Buffalo, N.Y.-based Roswell Park Comprehensive…

After decades of slow progress, a personalized cancer vaccine has shown a clear benefit in a phase 3 trial for the first time. Cancer leaders are now weighing how soon a vaccine built from a patient’s own tumor could become…

Philadelphia-based Penn Medicine has established the Troiano Brain Tumor Center with a $35 million initiative built to translate the system’s cell therapy research into treatment. Penn Medicine said Oct. 29 the center will focus on early-phase clinical trials and coordinated…